Facility

Merck MilliporeSigma Sheboygan, WI Facility

Operated by Merck KGaA (MilliporeSigma in US)USmanufacturing

Groundbreaking July 2022. First US lateral flow membrane production facility. Funded by €121M US DoD/HHS contract. Adds >50% capacity to existing Cork lines. Directly responds to COVID-revealed concentration risk.

0

Inputs produced

0

Goods downstream

0

Incidents on record

0

Stories